BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wolf SM, Ossorio PN, Berry SA, Greely HT, McGuire AL, Penny MA, Terry SF; LawSeq Framework Task Force. Integrating Rules for Genomic Research, Clinical Care, Public Health Screening and DTC Testing: Creating Translational Law for Translational Genomics. J Law Med Ethics 2020;48:69-86. [PMID: 32342790 DOI: 10.1177/1073110520916996] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Green ED, Gunter C, Biesecker LG, Di Francesco V, Easter CL, Feingold EA, Felsenfeld AL, Kaufman DJ, Ostrander EA, Pavan WJ, Phillippy AM, Wise AL, Dayal JG, Kish BJ, Mandich A, Wellington CR, Wetterstrand KA, Bates SA, Leja D, Vasquez S, Gahl WA, Graham BJ, Kastner DL, Liu P, Rodriguez LL, Solomon BD, Bonham VL, Brody LC, Hutter CM, Manolio TA. Strategic vision for improving human health at The Forefront of Genomics. Nature 2020;586:683-92. [PMID: 33116284 DOI: 10.1038/s41586-020-2817-4] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 20.5] [Reference Citation Analysis]
2 Greely HT. The Future of DTC Genomics and the Law. J Law Med Ethics 2020;48:151-60. [PMID: 32342782 DOI: 10.1177/1073110520917003] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Wolf SM, Clayton EW, Lawrenz F. Introduction: The Crucial Role of Law in Supporting Successful Translation of Genomics into Clinical Care. J Law Med Ethics 2020;48:7-10. [PMID: 32342780 DOI: 10.1177/1073110520916993] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Wagner JK, Meyer MN. Genomic medicine and the "loss of chance" medical malpractice doctrine. HGG Adv 2021;2:100032. [PMID: 34250511 DOI: 10.1016/j.xhgg.2021.100032] [Reference Citation Analysis]
5 Mann SP, Treit PV, Geyer PE, Omenn GS, Mann M. Ethical Principles, Constraints and Opportunities in Clinical Proteomics. Mol Cell Proteomics 2021;:100046. [PMID: 33453411 DOI: 10.1016/j.mcpro.2021.100046] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
6 Wand H, Knowles JW, Clarke SL. The need for polygenic score reporting standards in evidence-based practice: lipid genetics use case. Curr Opin Lipidol 2021;32:89-95. [PMID: 33538426 DOI: 10.1097/MOL.0000000000000733] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Wouters RHP, van der Graaf R, Rigter T, Bunnik EM, Ploem MC, de Wert GMWR, Dondorp WJ, Cornel MC, Bredenoord AL. Towards a Responsible Transition to Learning Healthcare Systems in Precision Medicine: Ethical Points to Consider. J Pers Med 2021;11:539. [PMID: 34200580 DOI: 10.3390/jpm11060539] [Reference Citation Analysis]